Poly Medicure share price rose 1.5 percent in the early trade on September 4 following the acquisition of cardiology catheter solutions manufacturer.
At 09:17 hrs Poly Medicure was quoting at Rs 2,098.25, up Rs 29.30, or 1.42 percent, on the BSE.
"..... signs definitive agreements to acquire 90 percent stake in PendraCare Group consisting of PendraCare Holdings and Wellinq Medical from Wellinq Holdings B.V. at an Enterprise value of Euro 18.3mn," the company said in its exchange filing.
The balance 10 percnet stake to be acquired in 2030 basis actual EBITDA for CY 2029, it added.
PendraCare Group, based in Leek, Netherlands, is an independent and ISO certified developer and manufacturer of cardiology catheter solutions, including guiding and diagnostic catheters.
This “bolt-on” acquisition provides Polymed with an opportunity to scale its cardiology business globally with immediate access to world’s most regulated markets of Europe and the US, company added.
Catch all market action in our live blog
The 30th Annual General Meeting of the company, scheduled to be held on Thursday, September 25, 2025.
The share touched a 52-week high of Rs 3,350.00 and a 52-week low of Rs 1,822.65 on 01 November, 2024 and 13 August, 2025, respectively.
Currently, the stock is trading 37.37 percent below its 52-week high and 15.12 percent above its 52-week low.
The market capitalisation of the company stands at Rs 21,260.67 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
